Stephen Zachary
Director/Board Member bij Tolerion, Inc.
Profiel
Stephen Zachary is currently a Director at Tolerion, Inc., Day Zero Diagnostics, Inc., DICE Molecules SV, Inc., and Sands Capital Ventures LLC.
He previously worked as a Director at Acumen Pharmaceuticals, Inc., SeLux Diagnostics, Inc., and PTC Therapeutics GT, Inc. Additionally, he served as an Independent Director at DiCE Therapeutics, Inc. Dr. Zachary holds an undergraduate degree from Washington & Lee University and a doctorate from The Johns Hopkins University School of Medicine.
Actieve functies van Stephen Zachary
Bedrijven | Functie | Begin |
---|---|---|
Sands Capital Ventures LLC
Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | Private Equity Analyst | 01-11-2016 |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Director/Board Member | - |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Director/Board Member | - |
Day Zero Diagnostics, Inc.
Day Zero Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Day Zero Diagnostics, Inc. operates as an infectious disease diagnostic firm. It develops technologies to modernize the treatment for infectious diseases. The company was founded by Jong Leeis, Miriam Huntley, Doug Kwon, Melis Anahtar, and Dougal Maclaurin and is headquartered in Boston, MA. | Director/Board Member | - |
Eerdere bekende functies van Stephen Zachary
Bedrijven | Functie | Einde |
---|---|---|
DICE THER | Director/Board Member | 31-03-2022 |
PTC Therapeutics GT, Inc.
PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a private company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Corporate Officer/Principal | 01-08-2018 |
ACUMEN PHARMACEUTICALS, INC. | Director/Board Member | - |
SeLux Diagnostics, Inc.
SeLux Diagnostics, Inc. Medical SpecialtiesHealth Technology SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA. | Director/Board Member | - |
Opleiding van Stephen Zachary
Washington & Lee University | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ACUMEN PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Sands Capital Ventures LLC
Sands Capital Ventures LLC Investment ManagersFinance Sands Capital Ventures LLC (Sands Capital Ventures) is a venture capital subsidiary founded in 2010 by Frank Sands. The firm is headquartered in Arlington, Virginia. | Finance |
Tolerion, Inc.
Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Health Technology |
DICE Therapeutics, Inc.
DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
Day Zero Diagnostics, Inc.
Day Zero Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Day Zero Diagnostics, Inc. operates as an infectious disease diagnostic firm. It develops technologies to modernize the treatment for infectious diseases. The company was founded by Jong Leeis, Miriam Huntley, Doug Kwon, Melis Anahtar, and Dougal Maclaurin and is headquartered in Boston, MA. | Commercial Services |
SeLux Diagnostics, Inc.
SeLux Diagnostics, Inc. Medical SpecialtiesHealth Technology SeLux Diagnostics, Inc. develops universal synthetic amplifier technology equipment. The firm offers Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. The company was founded by Eric Stern and Aleksander Vacic in 2014 and is headquartered in Charlestown, MA. | Health Technology |
PTC Therapeutics GT, Inc.
PTC Therapeutics GT, Inc. Medical SpecialtiesHealth Technology Part of PTC Therapeutics, Inc., PTC Therapeutics GT, Inc. is a private company that innovates DNA therapeutics to provide long-term efficacy for patients with debilitating and fatal diseases. The company is based in Lynnfield, MA. The company was founded by Chrystyna Bedrij Stecyk. | Health Technology |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Finance |